✦
Summary
LabOS is an AI-XR co-scientist platform for modern laboratories that connects agentic reasoning with real-world experiment execution. It is designed to help scientists move from dry-lab planning to wet-lab action by combining multimodal AI agents, XR smart glasses, lab-specialized vision-language models, and documentation workflows. The goal is to let AI see what researchers see, reason about protocol state, and guide or verify physical experimental steps in real time.
Key Features
Combines agentic AI reasoning with XR smart-glass guidance for laboratory workflows.
Uses lab-specialized vision-language models to interpret egocentric experiment activity.
Aligns live actions against reference protocols to detect deviations and verify outcomes.
Supports hands-free voice and gesture interaction during wet-lab execution.
Includes multi-agent planning, development, critique, and tool-creation components.
Captures materials, steps, and observations for automated experiment documentation.
Connects dry-lab computational planning with wet-lab validation and execution.
Provides LabSuperVision benchmark resources for evaluating lab-focused VLMs and agents.
About LabOS
The system is organized around seeing, reasoning, and acting. Its XR layer captures egocentric lab workflows and supports hands-free interaction, while a lab-trained VLM aligns live actions against reference protocols, detects deviations, verifies outcomes, and contributes to spatial digital-twin understanding. A self-evolving multi-agent core with manager, planner, developer, critic, and tool-creation capabilities can expand analysis tools and refine experimental workflows.
LabOS is valuable for biomedical research, materials science, and automated laboratory operations where mistakes, protocol drift, and documentation overhead slow discovery. By pairing AI agents with human scientists and physical lab contexts, it acts less like a generic chatbot and more like an embodied research operating system. The platform appears to offer public research materials and sign-up based access, so this listing treats it as a freemium research platform rather than a fully open or purely paid product.